Literature DB >> 32769426

ACG Clinical Guidelines: Clinical Use of Esophageal Physiologic Testing.

C Prakash Gyawali1, Dustin A Carlson2, Joan W Chen3, Amit Patel4, Robert J Wong5, Rena H Yadlapati6.   

Abstract

Esophageal symptoms are common and may indicate the presence of gastroesophageal reflux disease (GERD), structural processes, motor dysfunction, behavioral conditions, or functional disorders. Esophageal physiologic tests are often performed when initial endoscopic evaluation is unrevealing, especially when symptoms persist despite empiric management. Commonly used esophageal physiologic tests include esophageal manometry, ambulatory reflux monitoring, and barium esophagram. Functional lumen imaging probe (FLIP) has recently been approved for the evaluation of esophageal pressure and dimensions using volumetric distension of a catheter-mounted balloon and as an adjunctive test for the evaluation of symptoms suggestive of motor dysfunction. Targeted utilization of esophageal physiologic tests can lead to definitive diagnosis of esophageal disorders but can also help rule out organic disorders while making a diagnosis of functional esophageal disorders. Esophageal physiologic tests can evaluate obstructive symptoms (dysphagia and regurgitation), typical and atypical GERD symptoms, and behavioral symptoms (belching and rumination). Certain parameters from esophageal physiologic tests can help guide the management of GERD and predict outcomes. In this ACG clinical guideline, we used the Grading of Recommendations Assessment, Development and Evaluation process to describe performance characteristics and clinical value of esophageal physiologic tests and provide recommendations for their utilization in routine clinical practice.

Entities:  

Mesh:

Year:  2020        PMID: 32769426      PMCID: PMC9468980          DOI: 10.14309/ajg.0000000000000734

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   12.045


  174 in total

1.  Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time.

Authors:  L Frazzoni; M Frazzoni; N de Bortoli; S Tolone; M Furnari; I Martinucci; H Bertani; S Marchi; R Conigliaro; L Fuccio; V Savarino; E Savarino
Journal:  Neurogastroenterol Motil       Date:  2017-05-25       Impact factor: 3.598

2.  Clinical outcomes of laryngopharyngeal reflux treatment: A systematic review and meta-analysis.

Authors:  Jerome R Lechien; Sven Saussez; Antonio Schindler; Petros D Karkos; Abdul Latif Hamdan; Bernard Harmegnies; Lisa G De Marrez; Camille Finck; Fabrice Journe; Marianne Paesmans; Michael F Vaezi
Journal:  Laryngoscope       Date:  2018-12-30       Impact factor: 3.325

3.  Distal mean nocturnal baseline impedance on pH-impedance monitoring predicts reflux burden and symptomatic outcome in gastro-oesophageal reflux disease.

Authors:  A Patel; D Wang; N Sainani; G S Sayuk; C P Gyawali
Journal:  Aliment Pharmacol Ther       Date:  2016-08-24       Impact factor: 8.171

4.  The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.

Authors:  Nimish Vakil; Sander V van Zanten; Peter Kahrilas; John Dent; Roger Jones
Journal:  Am J Gastroenterol       Date:  2006-08       Impact factor: 10.864

5.  The Chicago Classification of esophageal motility disorders, v3.0.

Authors:  P J Kahrilas; A J Bredenoord; M Fox; C P Gyawali; S Roman; A J P M Smout; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2014-12-03       Impact factor: 3.598

6.  Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn.

Authors:  Arne Kandulski; Jochen Weigt; Carlos Caro; Doerthe Jechorek; Thomas Wex; Peter Malfertheiner
Journal:  Clin Gastroenterol Hepatol       Date:  2014-12-09       Impact factor: 11.382

7.  Ineffective esophageal motility phenotypes following fundoplication in gastroesophageal reflux disease.

Authors:  M D Mello; A R Shriver; Y Li; A Patel; C P Gyawali
Journal:  Neurogastroenterol Motil       Date:  2015-11-17       Impact factor: 3.598

8.  Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.

Authors:  Jason M Pritchett; Muhammad Aslam; James C Slaughter; Reid M Ness; C Gaelyn Garrett; Michael F Vaezi
Journal:  Clin Gastroenterol Hepatol       Date:  2009-03-09       Impact factor: 11.382

9.  Characteristics of belching, swallowing, and gastroesophageal reflux in belching patients based on Rome III criteria.

Authors:  Jianbo Li; Yinglian Xiao; Sui Peng; Jinkun Lin; Minhu Chen
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

10.  Assessment of Clinical Outcomes after Peroral Endoscopic Myotomy via Esophageal Distensibility Measurements with the Endoluminal Functional Lumen Imaging Probe.

Authors:  In Kyung Yoo; Sang Ah Choi; Won Hee Kim; Sung Pyo Hong; Ozlem Ozer Cakir; Joo Young Cho
Journal:  Gut Liver       Date:  2019-01-15       Impact factor: 4.519

View more
  18 in total

Review 1.  Achalasia.

Authors:  Edoardo Savarino; Shobna Bhatia; Sabine Roman; Daniel Sifrim; Jan Tack; Sarah K Thompson; C Prakash Gyawali
Journal:  Nat Rev Dis Primers       Date:  2022-05-05       Impact factor: 52.329

Review 2.  ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.

Authors:  Philip O Katz; Kerry B Dunbar; Felice H Schnoll-Sussman; Katarina B Greer; Rena Yadlapati; Stuart Jon Spechler
Journal:  Am J Gastroenterol       Date:  2022-01-01       Impact factor: 10.864

3.  Classifying Esophageal Motility by FLIP Panometry: A Study of 722 Subjects With Manometry.

Authors:  Dustin A Carlson; C Prakash Gyawali; Abraham Khan; Rena Yadlapati; Joan Chen; Reena V Chokshi; John O Clarke; Jose M Garza; Anand S Jain; Philip Katz; Vani Konda; Kristle Lynch; Felice H Schnoll-Sussman; Stuart J Spechler; Marcelo F Vela; Jacqueline E Prescott; Alexandra J Baumann; Erica N Donnan; Wenjun Kou; Peter J Kahrilas; John E Pandolfino
Journal:  Am J Gastroenterol       Date:  2021-12-01       Impact factor: 10.864

4.  Optimal Wireless Reflux Monitoring Metrics to Predict Discontinuation of Proton Pump Inhibitor Therapy.

Authors:  Rena Yadlapati; C Prakash Gyawali; Melina Masihi; Dustin A Carlson; Peter J Kahrilas; Billy Darren Nix; Anand Jain; Joseph R Triggs; Michael F Vaezi; Leila Kia; Alexander Kaizer; John E Pandolfino
Journal:  Am J Gastroenterol       Date:  2022-06-10       Impact factor: 12.045

Review 5.  Esophageal Motility Disorders: Current Approach to Diagnostics and Therapeutics.

Authors:  Dhyanesh A Patel; Rena Yadlapati; Michael F Vaezi
Journal:  Gastroenterology       Date:  2022-02-25       Impact factor: 33.883

Review 6.  An update on current treatment strategies for laryngopharyngeal reflux symptoms.

Authors:  Amanda J Krause; Erin H Walsh; Philip A Weissbrod; Tiffany H Taft; Rena Yadlapati
Journal:  Ann N Y Acad Sci       Date:  2021-12-17       Impact factor: 6.499

Review 7.  Factors that Impact Day-to-Day Esophageal Acid Reflux Variability and Its Diagnostic Significance for Gastroesophageal Reflux Disease.

Authors:  Steven D Ma; Vandan Patel; Rena Yadlapati
Journal:  Dig Dis Sci       Date:  2022-04-19       Impact factor: 3.487

8.  Prediction of Esophageal Retention: A Study Comparing High-Resolution Manometry and Functional Luminal Imaging Probe Panometry.

Authors:  Dustin A Carlson; Alexandra J Baumann; Jacqueline E Prescott; Jacob M Schauer; Amanda Krause; Erica N Donnan; Wenjun Kou; Peter J Kahrilas; John E Pandolfino
Journal:  Am J Gastroenterol       Date:  2021-10-01       Impact factor: 12.045

Review 9.  A practical approach to the evaluation and management of gastrointestinal symptoms in patients with systemic sclerosis.

Authors:  Timothy Kaniecki; Tsion Abdi; Zsuzsanna H McMahan
Journal:  Best Pract Res Clin Rheumatol       Date:  2021-03-04       Impact factor: 4.991

Review 10.  Use of the Functional Lumen Imaging Probe in Clinical Esophagology.

Authors:  Edoardo Savarino; Massimiliano di Pietro; Albert J Bredenoord; Dustin A Carlson; John O Clarke; Abraham Khan; Marcelo F Vela; Rena Yadlapati; Daniel Pohl; John E Pandolfino; Sabine Roman; C Prakash Gyawali
Journal:  Am J Gastroenterol       Date:  2020-11       Impact factor: 12.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.